SIGA Technologies IncSIGA received approximately $16 million in international procurement orders for oral TPOXX (tecovirimat) in August and early September.
The orders include an approximate $10 million order by the European Commission and approximately $6 million of orders from two countries in the Asia Pacific region, one of which is a new customer.
The order from the European Commission is for emergency short-term stockpiling and/or deployment of oral TPOXX (tecovirimat) in connection with the monkeypox outbreak.
In addition to procuring oral TPOXX through the funding of direct purchases, the European Commission is also coordinating country-level procurement through the use of a joint procurement mechanism.
SIGA expects to complete the delivery of these most recent orders in 2022. To date this year, including the recent orders, SIGA has received approximately $76 million of international orders for oral TPOXX. It is expected that at least $65 million of these orders will be delivered in 2022.
Price Action: SIGA shares are up 0.39% at $10.32 on the last check Monday.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
